Ambio’s cofounder, Jonathan Dickinson, recently published a series of case studies in the journal Anthropology of Consciousness that aims to better describe the ibogaine experience. The report highlights a sense of ‘intersubjectivity’ that many people...
In early 2014, I had the honor and pleasure of interviewing Claudio Naranjo, the late Chilean psychiatrist, about his early work with lower doses of ibogaine (which he mixed with harmaline) in the context of psychotherapy. Claudio Naranjo’s book The Healing...
A research team at Columbia University soon hopes to show whether or not ibogaine, an extract of iboga — a psychoactive West-African plant medicine — may have unique benefits in the treatment of Parkinson’s disease. The majority of existing research on ibogaine has...
Originally published on Reality Sandwich. Ibogaine, the primary alkaloid of iboga, a psychoactive African root bark, has been administered to thousands of people in the last three decades as an experimental medication with promising efficacy in the treatment of...
Ibogaine in the Psychospiritual Treatment of Addiction Feeding the Hungry Ghosts: Ibogaine and the Psychospiritual Treatment of Addiction originally appeared in the Spring 2010 bulletin for the Multidisciplinary Association for Psychedelic Studies (MAPS), and was...
Two psychedelic advocates say the mental health industry doesn’t know what it’s doing with its drug studies Supposedly, we are living through a “psychedelic renaissance.” From ketamine antidepressants to MDMA-assisted psychotherapy, the medical...
